ENTRY       D01583                      Drug
NAME        Pirfenidone (JAN/USAN/INN);
            Esbriet (TN)
PRODUCT     ESBRIET (Genentech)
  GENERIC   PIRFENIDONE (Accord Healthcare)
            PIRFENIDONE (Alembic Pharmaceuticals Limited)
            PIRFENIDONE (Alembic Pharmaceuticals)
            PIRFENIDONE (Amneal Pharmaceuticals NY LLC)
            PIRFENIDONE (Amneal Pharmaceuticals NY LLC)
            PIRFENIDONE (Amneal Pharmaceuticals NY LLC)
            PIRFENIDONE (Amneal Pharmaceuticals NY LLC)
            PIRFENIDONE (Camber Pharmaceuticals)
            PIRFENIDONE (Cipla USA)
            PIRFENIDONE (Cipla USA)
            PIRFENIDONE (EXELAN PHARMACEUTICALS)
            PIRFENIDONE (EXELAN PHARMACEUTICALS)
            PIRFENIDONE (Laurus Labs Limited)
            PIRFENIDONE (MSN LABORATORIES PRIVATE LIMITED)
            PIRFENIDONE (Micro Labs Limited)
            PIRFENIDONE (Novadoz Pharmaceuticals LLC)
            PIRFENIDONE (Sandoz)
            PIRFENIDONE (Sandoz)
            PIRFENIDONE (ScieGen Pharmaceuticals)
            PIRFENIDONE (ScieGen Pharmaceuticals)
            PIRFENIDONE (Teva Pharmaceuticals)
FORMULA     C12H11NO
EXACT_MASS  185.0841
MOL_WEIGHT  185.2218
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG02855  CYP2E1 substrate
REMARK      Therapeutic category: 3999
            ATC code: L04AX05
            Product: D01583<JP/US>
EFFICACY    Analgesic, Antifibrotic, Anti-inflammatory, Antipyretic
  DISEASE   Idiopathic pulmonary fibrosis [DS:H01299]
COMMENT     Phenylpyridine derivative
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
            IL1 [HSA:3552 3553] [KO:K04383 K04519]
            IL6 [HSA:3569] [KO:K05405]
            CCL2 [HSA:6347] [KO:K14624]
            IL10 [HSA:3586] [KO:K05443]
  PATHWAY   hsa04060(3552+3553+3569+3586+6347+7124)  Cytokine-cytokine receptor interaction
            hsa04218(3552+3569)  Cellular senescence
            hsa04350(7124)  TGF-beta signaling pathway
            hsa04640(3552+3553+3569+7124)  Hematopoietic cell lineage
            hsa04668(3553+3569+6347+7124)  TNF signaling pathway
METABOLISM  Enzyme: CYP1A2 [HSA:1544]; CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP2D6 [HSA:1565], CYP2E1 [HSA:1571]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AX Other immunosuppressants
                 L04AX05 Pirfenidone
                  D01583  Pirfenidone (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Pulmonary Fibrosis Agents
               Pirfenidone
                D01583  Pirfenidone (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D01583  Pirfenidone (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D01583  Pirfenidone
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D01583  Pirfenidone
              DG01642  CYP2C9 substrate
               D01583  Pirfenidone
              DG01639  CYP2C19 substrate
               D01583  Pirfenidone
              DG01644  CYP2D6 substrate
               D01583  Pirfenidone
              DG02855  CYP2E1 substrate
               D01583  Pirfenidone
            Drug classes [BR:br08332]
             Immunological agent
              DG02019  Interleukin inhibitor
               D01583  Pirfenidone
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL1
                 D01583  Pirfenidone (JAN/USAN/INN) &lt;JP/US&gt;
                IL6
                 D01583  Pirfenidone (JAN/USAN/INN) &lt;JP/US&gt;
                IL10
                 D01583  Pirfenidone (JAN/USAN/INN) &lt;JP/US&gt;
               Chemokines
                CCL2
                 D01583  Pirfenidone (JAN/USAN/INN) &lt;JP/US&gt;
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D01583  Pirfenidone (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01583
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01583
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01583
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01583
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01583
DBLINKS     CAS: 53179-13-8
            PubChem: 7848646
            ChEBI: 32016
            LigandBox: D01583
            NIKKAJI: J10.084F
ATOM        14
            1   C8x C    27.6234  -19.5554
            2   C8x C    27.6234  -18.1551
            3   C8y C    26.4078  -17.4550
            4   C8x C    25.1992  -18.1551
            5   N4y N    25.1992  -19.5554
            6   C8y C    26.4078  -20.2556
            7   C1a C    26.4061  -16.0546
            8   O5x O    26.4061  -21.6559
            9   C8y C    23.9862  -20.2547
            10  C8x C    22.7759  -19.5520
            11  C8x C    21.5627  -20.2512
            12  C8x C    21.5617  -21.6515
            13  C8x C    22.7739  -22.3527
            14  C8x C    23.9872  -21.6533
BOND        15
            1     3   7 1
            2     1   2 2
            3     6   8 2
            4     2   3 1
            5     5   9 1
            6     3   4 2
            7     4   5 1
            8     5   6 1
            9     6   1 1
            10    9  10 2
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14   9 1
///
